Polaris Renewable Energy (TSE:PIF – Free Report) had its price target upped by Raymond James from C$19.00 to C$21.00 in a research note released on Friday, BayStreet.CA reports. The brokerage currently has a strong-buy rating on the stock. Raymond James also issued estimates for Polaris Renewable Energy’s FY2024 earnings at $0.55 EPS, Q2 2025 earnings at $0.19 EPS, Q3 2025 earnings at $0.15 EPS, Q4 2025 earnings at $0.25 EPS and FY2025 earnings at $0.75 EPS.
Separately, National Bankshares raised their price objective on Polaris Renewable Energy from C$19.00 to C$20.00 and gave the company an “outperform” rating in a research report on Tuesday, July 16th.
View Our Latest Research Report on Polaris Renewable Energy
Polaris Renewable Energy Stock Up 2.5 %
Polaris Renewable Energy Cuts Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 22nd. Shareholders of record on Friday, November 22nd will be paid a dividend of $0.203 per share. This represents a $0.81 dividend on an annualized basis and a dividend yield of 6.55%. The ex-dividend date is Friday, November 8th. Polaris Renewable Energy’s dividend payout ratio is 164.00%.
Polaris Renewable Energy Company Profile
Polaris Renewable Energy Inc engages in the acquisition, exploration, development, and operation of renewable energy projects in Latin America. It operates 82 megawatts (MW) net geothermal facility in Nicaragua; and 3 run-of-river hydroelectric facilities in Peru, with combined capacity of approximately 33 MW; a 25 MW solar plant facility in the Dominican Republic; a 6 MW run-of-river hydroelectric facility in Ecuador; and a 10 MW solar plant in Panama.
Further Reading
- Five stocks we like better than Polaris Renewable Energy
- How to Read Stock Charts for Beginners
- Intel: Is Now the Time to Be Brave?Â
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Best Stocks Under $5.00
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Polaris Renewable Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polaris Renewable Energy and related companies with MarketBeat.com's FREE daily email newsletter.